Skip to content
Search

Latest Stories

Submit Guest Post

Reckitt starts strategic review of its infant formula business in China

RECKITT BENCKISER has launched a strategic review of Mead Johnson, the infant formula business in China, four years after the $18 billion acquisition of the brand.

Though there are reports of a possible sale, Laxman Narasimhan, Reckitt’s chief executive, told The Times that it was premature to speculate on the outcome.


Mead Johnson was more expensive than all of Reckitt Benckiser’s other acquisitions combined, reports said.

This week, the group announced the sale of Scholl, its footcare products business, to Yellow Wood Partners, the US private equity firm.

It was announced alongside the acquisition of the Biofreeze pain relief brand from Performance Health, owned by US private equity firm Madison Dearborn Partners.

Narasimhan, chief executive since September 2019 and a former Pepsico executive, has been trying to revive trading after years of sluggish sales and a series of costly mishaps under Rakesh Kapoor, his predecessor. They included an unsuccessful product launch at Scholl and disruption at a baby formula factory in the Netherlands.

Meanwhile, Reckitt posted an 11.8 per cent rise in total like-for-like sales growth to almost £14bn for the year to December, its largest increase since the group was formed in 1999.

The jump was driven by its hygiene business, where sales rose 19.5 per cent to £5.8bn amid increased concerns about cleanliness because of the pandemic. Sales in its health division, which include Dettol, jumped 12.1 per cent to almost £4.9bn.

Group sales in its fourth quarter were up 10.2 per cent, reports said.

Profit before tax rose to £1.9bn from a loss of £2.1bn in 2019.

Reckitt forecast sales this year in the range of flat to 2 per cent and raised target cost savings to £1.6bn over three years, from £1.3bn.

While commenting on the numbers, Narasimhan said that Reckitt is positioned to benefit from the post-pandemic world.

When the company acquired Mead Johnson, the manufacturer behind the Enfamil infant formula brand, in 2017, the deal was met with stinging criticism.

Reckitt was seeking to expand its higher-margin consumer healthcare business and to exploit growing demand for baby formula, particularly in China, where demand was expected to increase after the country ended its one-child policy in 2015 and with a growing number of women in the workforce.

Revenues in the infant nutrition business fell 4 per cent last year, despite a strong performance in North America from Enfamil.

Reckitt is based in Slough, operates in more than 60 countries and employs about 40,000 people.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

UK-EU Deal

British Prime Minister Andy Burnham (C) poses with European Commission President Ursula von der Leyen (L) and European Council President Antonio Costa (R) as he arrives at the EU Council for a EU-UK Summit,

Getty Images

A decade after Brexit, Britain is rewriting its relationship with Europe. What has changed?

  • A food trade agreement due in 2028 aims to remove most health certificates and border checks on goods moving between Britain and the EU.
  • A new youth scheme will give 100,000 people from each side, aged 18 to 31, the opportunity to live, work and study across the Channel.
  • The government estimates the package could add around £17 billion a year to the UK economy by 2040.

Britain is taking another step towards closer relations with the European Union, a decade after the referendum that set it on the path to leaving the bloc.

At a summit in Brussels on Friday (20), Prime Minister Andy Burnham and European leaders agreed a package covering food trade, carbon markets, youth mobility and security cooperation. The agreements are intended to reduce some of the practical barriers created by Brexit while giving businesses and younger people greater access to opportunities across Europe.

Keep ReadingShow less